Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

2.99
-0.1300-4.17%
Post-market: 2.98-0.0100-0.33%19:59 EDT
Volume:323.26K
Turnover:981.86K
Market Cap:140.72M
PE:-1.14
High:3.11
Open:3.11
Low:2.99
Close:3.12
52wk High:8.77
52wk Low:2.15
Shares:47.06M
Float Shares:38.02M
Volume Ratio:0.37
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6200
EPS(LYR):-2.5130
ROE:-46.48%
ROA:-16.67%
PB:0.59
PE(LYR):-1.19

Loading ...

BRIEF-Quanterix Q1 Net Income USD -17.541 Million

Reuters
·
May 07

Quanterix Releases Financial Results for the First Quarter of 2026

THOMSON REUTERS
·
May 07

Quanterix Q1 Product Revenue USD 25.479 Million

THOMSON REUTERS
·
May 07

Quanterix - Q1 Revenue USD 36.4 Million

THOMSON REUTERS
·
May 07

Quanterix Q1 Basic EPS USD -0.37

THOMSON REUTERS
·
May 07

Quanterix Corp: Reaffirming Its Guidance for 2026

THOMSON REUTERS
·
May 07

Quanterix partners with Tempus to integrate Alzheimer’s blood biomarker test into workflows

Reuters
·
May 06

Lucent Diagnostics Announces Collaboration With Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing Into Clinical Workflows

THOMSON REUTERS
·
May 06

Quanterix Corp expected to post a loss of 54 cents a share - Earnings Preview

Reuters
·
May 05

Press Release: Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

Dow Jones
·
Apr 24

Quanterix schedules first-quarter results conference call

Reuters
·
Apr 24

Quanterix announces annual shareholder meeting via webcast

Reuters
·
Apr 24

Quanterix Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Apr 21

Quanterix price target lowered to $4 from $8 at Canaccord

TIPRANKS
·
Apr 20

Quanterix, PreludeDX highlights AidaBREAST multi-omic assay

TIPRANKS
·
Apr 17

Quanterix highlights AidaBREAST study predicting breast cancer recurrence risk, radiation benefit

Reuters
·
Apr 17

Quanterix debuts Content Innovation Engine at AACR 2026

TIPRANKS
·
Apr 15

Quanterix to debut Content Innovation Engine at AACR Annual Meeting

Reuters
·
Apr 15

Quanterix sets 2026 annual shareholder meeting date; proposal and nomination submission deadline moves to April 6, 2026

Reuters
·
Mar 28

Quanterix Chief Legal Officer Daniel Char files initial beneficial ownership statement

Reuters
·
Mar 25